MPM Capital is a venture capital firm founded in 1996. The firm was founded by Luke Evnin and Ansbert Gadicke. It is primarily based in Cambridge, Massachusetts although it also has offices in Brisbane, California and Kansas City, Kansas. As of March 2019, the firm is managing 33 active companies in its portfolio and has sold off its ownership in 199 companies. Its most recent investment was in Harpoon Therapeutics on November 2018, a company developing clinical-stage immunotherapy .
MPM Capital specializes in funding life sciences and healthcare companies. It provides financing at various stages of development, from seed to buyout. The firm invests on companies worldwide, but it prioritizes funding companies that are based in the United States, Europe, and India. Since its establishment, the firm has managed to amass a total fund of $2.9 billion across ten funding series. Its most recent funding round was held in February 2019 which collected $400 million.
Associated investment funds
Chief Financial Officer
Chief Operating Officer
Documentaries, videos and podcasts